Back to Search
Start Over
Multiantigenic subunitary vaccines against tuberculosis in clinical trials: Where do we stand and where do we need to go?
- Source :
-
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2016 May 03; Vol. 12 (5), pp. 1193-5. Date of Electronic Publication: 2016 Apr 06. - Publication Year :
- 2016
-
Abstract
- The idea of presenting this commentary is to bring attention to the current status of clinical tests from several multiantigen vaccine candidates based on proteins produced by means of genetic engineering and molecular biology approaches and to suggest how new emerging technologies (OMICs) and bioinformatics might benefit vaccine development for better control of tuberculosis.
- Subjects :
- Antigens, Bacterial chemistry
BCG Vaccine immunology
Clinical Trials as Topic
Computational Biology methods
Drug Design
Humans
Tuberculosis Vaccines administration & dosage
Vaccines, Subunit genetics
Vaccines, Subunit standards
Antigens, Bacterial genetics
Antigens, Bacterial immunology
Mycobacterium tuberculosis immunology
Tuberculosis prevention & control
Tuberculosis Vaccines immunology
Vaccines, Subunit immunology
Subjects
Details
- Language :
- English
- ISSN :
- 2164-554X
- Volume :
- 12
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Human vaccines & immunotherapeutics
- Publication Type :
- Academic Journal
- Accession number :
- 27049797
- Full Text :
- https://doi.org/10.1080/21645515.2015.1136760